Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.33 |
| ▸ | CYP2C8 | P10632 | 1/20 | 0.32 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.32 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | MPO | P05164 | 1/20 | 0.31 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.31 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.31 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4601776 | 0.89 | TAAR1 (0.35) | TAAR1ADRA1ASIGMAR1 | |
| SCHEMBL11560689 | 0.83 | ALOX5 (0.49) | ALOX5PTGS2 | |
| SCHEMBL3547466 | 0.80 | HMGCR (0.43) | TAAR1ALOX5PTGS2SMN1; SMN2ADRA1A | |
| SCHEMBL7388700 | 0.79 | TAAR1 (0.35) | TAAR1SMN1; SMN2MPOADRA1AMTNR1A | |
| SCHEMBL27588198 | 0.79 | TAAR1 (0.35) | TAAR1ADRA1ASIGMAR1 | |
| SCHEMBL7691596 | 0.78 | IDO1 (0.37) | TAAR1ADRA1ASIGMAR1 | |
| SCHEMBL2806331 | 0.77 | SMN1; SMN2 (0.40) | SMN1; SMN2HPGD | |
| SCHEMBL6313680 | 0.76 | HTR2A (0.46) | — | |
| SCHEMBL3546384 | 0.76 | CYP1A2 (0.33) | SMN1; SMN2HPGD | |
| SCHEMBL457842 | 0.76 | TAAR1 (0.37) | TAAR1PTGS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2189442-B1 | Process and intermediates for the preparation of aliskiren | KRKA TOVARNA ZDRAVIL D D NOVO MESTO (SI) | 2014-10-01 | — | — | EP | disclosed |
| EP-2189442-A1 | Process and intermediates for the preparation of aliskiren | Krka Tovarna Zdravil, D.D., Novo Mesto (SI) | 2010-05-26 | — | — | EP | disclosed |